尿,SETDB2SMAD3

Lanfang Li1, Shimin Jiang2, Qi Jin3

  • 1Beijing Key Laboratory for Immune-Mediated Inflammatory Diseases, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, 100029, China.

概括

组织素甲基转移酶SETDB2抑制了糖尿病病 (DKD) 中的 podocyte 功能障碍. 较低的SETDB2水平会使DKD恶化,而增加它则提供脏保护,将其确定为治疗标.